Início › Leucemia › Nova York

Ensaios clínicos de Leucemia em Nova York

26 estudos para Leucemia estão buscando participantes em locais em Nova York.

Cidades em Nova York

Texto oficial do estudo (Inglês)

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

Quetzal Site 4, Buffalo
Quetzal Site 2, The Bronx

RecrutandoFase 3

Idades de 18 a 71 · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT07504458

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

Montefiore Medical Center, New York

RecrutandoFase 1/2

30 Days · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT04065399

Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission

Weill Cornell, New York
Clinical Research Allicance, Westbury

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT06824168

A Phase II Study of the Menin Inhibitor Revumenib in Leukemia Associated With Upregulation of HOX Genes

Memorial Sloan Kettering Cancer Center, New York

RecrutandoFase 2

Idades 12 e acima · Todos os sexos · Atualizado em 11 de set. de 2026 · NCT06229912

Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)

Research Site, Rochester

RecrutandoFase 3

Idades de 18 a 18 · Todos os sexos · Atualizado em 8 de set. de 2026 · NCT07509151

Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP

Columbia University Medical Center New York Presbyterian, New York

RecrutandoFase 2

Idades de 1 a 18 · Todos os sexos · Atualizado em 2 de set. de 2026 · NCT07354074

First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.

Memorial Sloan Kettering Cancer Center, New York

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 1 de set. de 2026 · NCT07586618

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Roswell Park Comprehensive Cancer Center, Buffalo
Northwell Health, LLC PRIME, Lake Success
Memorial Sloan Kettering Cancer Center, New York
e mais 3

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 20 de ago. de 2026 · NCT06001788

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

State University of New York at Buffalo, Buffalo
Icahn School of Medicine at Mount Sinai, New York
Columbia University, New York
e mais 1

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 20 de ago. de 2026 · NCT07007312

AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia

Research Site, New York

RecrutandoFase 1/2

Idades 12 e acima · Todos os sexos · Atualizado em 19 de ago. de 2026 · NCT06137118

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

New York Medical College, Valhalla

RecrutandoFase 1/2

Idades de 13 a 90 · Todos os sexos · Atualizado em 6 de ago. de 2026 · NCT06533579

Genomically Profiling, Collecting, Archiving and Distributing Hematologic Malignancy Specimens

Albany Medical Center, Albany

RecrutandoEstudo observacional

Até 30 anos · Todos os sexos · Atualizado em 16 de jul. de 2026 · NCT04968834

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Weill Cornell Medicine - New York Presbyterian Hospital, New York

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 7 de jul. de 2026 · NCT07216443

Hairy Cell Leukemia Patient Data Registry

University of Rochester /Wilmot Cancer Institute, Rochester

RecrutandoEstudo observacional

Idades 18 e acima · Todos os sexos · Atualizado em 2 de jul. de 2026 · NCT02560883

Integrated Cancer Repository for Cancer Research

C.R. Wood Cancer Center, Glens Falls Hospital, Glens Falls
Faxton St. Luke's Healthcare, Mohawk Valley, Utica

RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos

Idades de 19 a 110 · Todos os sexos · Atualizado em 29 de jun. de 2026 · NCT02012699

CD4CAR for CD4+ Leukemia and Lymphoma

Albert Einstein Health Network, New York

RecrutandoFase 1

Idades 12 e acima · Todos os sexos · Atualizado em 24 de jun. de 2026 · NCT03829540

A Study of Revumenib and Mezigdomide in People With Leukemia

Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities), Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
e mais 1

RecrutandoFase 1/2

Idades 12 e acima · Todos os sexos · Atualizado em 22 de jun. de 2026 · NCT07356154

A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

Dren Investigational Site 1, New York
Dren Investigational Site 2, New York

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 17 de jun. de 2026 · NCT05475925

A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties

Memorial Sloan Kettering Cancer Center Suffolk - Commack (All protocol activities), Commack
Memorial Sloan Kettering Westchester (All protocol activities), Harrison
Memorial Sloan Kettering Cancer Center (All protocol activities), New York
e mais 1

RecrutandoVoluntários saudáveis bem-vindos

Idades 18 e acima · Todos os sexos · Atualizado em 26 de mai. de 2026 · NCT07052916

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park
University of Rochester, Rochester
Stony Brook University Medical Center, Stony Brook
e mais 1

RecrutandoEstudo observacional

Todas as idades · Todos os sexos · Atualizado em 18 de mai. de 2026 · NCT01790152

Cord Blood Transplantation in Children and Young Adults With Blood Cancer

Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York

RecrutandoFase 2

Até 26 anos · Todos os sexos · Atualizado em 14 de mai. de 2026 · NCT07566377

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

Roswell Park Comprehensive Cancer Center, Buffalo
New York University Langone Hospital - Long Island, Mineola
Perlmutter Cancer Center - 34th Street, New York
e mais 2

RecrutandoFase 2/3

Idades 18 e acima · Todos os sexos · Atualizado em 30 de abr. de 2026 · NCT04256317

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Roswell Park Comprehensive Cancer Center, Buffalo
New York - Presbyterian / Weill Cornell Medicine, New York
Mount Sinai - Ruttenberg Treatment Center, New York
e mais 2

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 13 de mar. de 2026 · NCT05735184

Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders

Memorial Sloan Kettering Commack, Commack
Memorial Sloan Kettering Westchester, Harrison
Memorial Sloan Kettering Cancer Center, New York
e mais 1

RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos

Todas as idades · Todos os sexos · Atualizado em 23 de jan. de 2026 · NCT00582621

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Buffalo
Massive Bio SYNERGY-AI site, Hempstead
Massive Bio SYNERGY-AI site, Manhasset
e mais 2

RecrutandoEstudo observacional

Todas as idades · Todos os sexos · Atualizado em 28 de out. de 2025 · NCT03452774

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

Roswell Park Cancer Institute, Buffalo
Memorial Sloan Kettering Cancer Center, New York

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 24 de set. de 2025 · NCT06501196

Fonte: ClinicalTrials.gov, dados obtidos em 1 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.